Assessment of paraoxonase activities in patients with knee osteoarthritis

References

• Keuttner K, Godberg VM. (eds) Osteoarthritic Disorders. Rosemont, IL: American Academy of Orthopedic Surgeons, 1995; 21–25.
   Google Scholar
• Mazzetti I, Grigolo B, Pulsatelli Let al. Differential roles of nitric oxide and oxygen radicals in chondrocytes affected by osteoarthritis and rheumatoid arthritis. CIM Sci 2001; 101: 593–599.
   Google Scholar
• Henrotin YE, Bruckner P, Pujol JP. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage 2003; 11: 747–755.
   PubMed Web of Science ®Google Scholar
• Sakurai H, Kohsaka H, Liu MF et al. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 1995; 96: 2357–2363.
   PubMed Web of Science ®Google Scholar
• Martel-Pelletier J, Alaeddine N, Pelletier JP. Cytokines and their role in the pathophysiology of osteoarthritis. Front Biosci 1999; 4: 694–703.
   PubMedGoogle Scholar
• Yudoh K, Nguyen T, Nakamura H, Hongo-Masuko K, Kato T, Nishioka K. Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function. Arthritis Res Ther 2005; 7: 380–391.
   PubMed Web of Science ®Google Scholar
• Plaa GL, Witschi H. Chemicals, drugs and lipid peroxidation. Annu Rev Pharmacol Toxicol 1976; 16: 125.
   PubMed Web of Science ®Google Scholar
• Mapp PI, Grootveld MC, Blake DR. Hypoxia, oxidative stress and rheumatoid arthritis. Br Med Bull 1995; 51: 419–436.
   PubMed Web of Science ®Google Scholar
• Sato M, Miyazaki T, Nagaya T et al. Antioxidants inhibit tumor necrosis factor-alpha mediated stimulation of interleukin-8, monocyte chemoattractant protein-1 and collagenase expression in cultured human synovial cells. J Rheumatol 1996; 23: 432–438.
   PubMed Web of Science ®Google Scholar
• Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994; 330: 1041–1046.
   PubMed Web of Science ®Google Scholar
• Stocker R, Keaney JF Jr. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004; 84: 1381–1478.
   PubMed Web of Science ®Google Scholar
• Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801–809.
   PubMed Web of Science ®Google Scholar
• Epstein S, Zhou YF, Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 1999; 100: 20–28.
   Web of Science ®Google Scholar
• Niemela S, Karttunen T, Korhonen T et al. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart 1996; 75: 573–575.
   Google Scholar
• Hoffmeister A, Rothenbacher D, Bode Get al. Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile. Arterioscler Thromb Vase Biol 2001; 21: 427–432.
   PubMed Web of Science ®Google Scholar
• Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915–924.
   PubMed Web of Science ®Google Scholar
• Canales A, Sanchez-Muniz FJ. Paraoxanase, something more than an enzyme? Med Clin ( Barc) 2003; 121: 537–548.
   PubMed Web of Science ®Google Scholar
• Blatter MC, James RW, Messmer S, Barja F, Pometta D. Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase. Eur J Biochem 1993; 211: 871–879.
   PubMedGoogle Scholar
• Aslan M, Kosecik M, Horoz M, Selek S, Celik H, Erel O. Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia. Atherosclerosis 2007; 191: 397–402.
   PubMed Web of Science ®Google Scholar
• Aviram M, Rosenblat M. Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences. Curr Opin Lipidol 2005; 16: 393–399.
   PubMed Web of Science ®Google Scholar
• Eckerson HW, Wyte MC, La Du BN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 1983; 35: 1126–1138.
   PubMed Web of Science ®Google Scholar
• Haagen L, Brock A. A new automated method for phenotyping arylesterase (E.C. 3.1.1.2.) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clin Biochem 1992; 30: 391–395.
   PubMedGoogle Scholar
• Nourooz Zadeh J. Ferrous ion oxidation in presence of xylenol orange for detection of lipid hydroperoxides in plasma. Methods Enzymo11999; 300: 58-62.
   Google Scholar
• Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70–77.
   PubMed Web of Science ®Google Scholar
• Hu ML, Louie S, Cross CE, Motchnik P, Halliwell B. Antioxidant protection against hypochlorous acid in human plasma. J Lab Clin Med 1993; 121: 257–262.
   PubMed Web of Science ®Google Scholar
• Mankin HJ, Mow VC, Buckwalter JA. Articular cartilage repair and osteoarthritis. In: Buckwalter JA, Einhorn TA, Simon SR. (eds) Orthopedic Basic Science, 2nd edn. Rosemont, IL: American Academy of Orthopedic Surgeons, 2000; 471-488.
   Google Scholar
• Melchiorri C, Meliconi R, Frizziero Let al. Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis. Arthritis Rheum 1998; 41: 2165–2174.
   PubMed Web of Science ®Google Scholar
• Grabowski PS, Wright PK, Van't Hof RJ, Helfrich MH, Ohshima H, Ralston SH. Immunolocalization of inducible nitric oxide synthase in synovium and cartilage in rheumatoid arthritis and osteoarthritis. Br J Rheumatol 1997; 36: 651–655.
   PubMedGoogle Scholar
• Loeser RF, Carlson CS, Del Carlo M, Cole A. Detection of nitrotyrosine in aging and osteoarthritic cartilage: correlation of oxidative damage with the presence of interleukin-lbeta and with chondrocyte resistance to insulin-like growth factor 1. Arthritis Rheum 2002; 46: 2349–2357.
   PubMed Web of Science ®Google Scholar
• Haidara MA, Yassin HZ, Rateb M, Ammar H, Zorkani MA. Role of oxidative stress in development of cardiovascular complications in diabetes mellitus. Curr Vase Pharmacol 2006; 4: 215–227.
   PubMedGoogle Scholar
• Arlt S, Kontush A, Muller-Thomsen T, Beisiegel U. [Lipid peroxidation as a common pathomechanism in coronary heart disease and Alzheimer disease]. Z Gerontol Geriatr 2001; 34: 461–465.
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Wag G, Puhl H. Lipid peroxidation and its role in atherosclerosis. Br Med Bull 1993; 49: 566–576.
   PubMed Web of Science ®Google Scholar
• Mackness MI, Harty D, Bhatnagar D et al. Serum paraoxonase activity in familial hypercholesterolemia and insulin-dependent diabetes mellitus. Atherosclerosis 1991; 86: 193–199.
   PubMed Web of Science ®Google Scholar
• Paragh G, Seres I, Balogh Z et al. The serum paraoxonase activity in patients with chronic renal failure and hyperlipidemia. Nephron 1998; 80: 166–170.
   PubMed Web of Science ®Google Scholar
• McElven J, Mackness MI, Colley CM et al. Distribution of paraoxon hydrolytic activity in the serum of patients after myocardial infarction. Clin Chem 1986; 32: 671–673.
   PubMed Web of Science ®Google Scholar
• Deakin S, Moren X, James RW. Very low density lipoproteins provide a vector for secretion of paraoxonase-1 from cells. Atherosclerosis 2005; 179: 17–25.
   PubMed Web of Science ®Google Scholar
• Rosenblat M, Karry R, Aviram M. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: Relevance to diabetes. Atherosclerosis 2006; 187: 74–81.
   PubMed Web of Science ®Google Scholar
• Mackness B, Durington P, McElduff P et al. Low paraoxonase activity predicts coronary events in the caterphilly prospective study. Circulation 2003; 107: 2775–2779.
   PubMed Web of Science ®Google Scholar
• Rozenberg O, Aviram M. S-Glutathionylation regulates HDL-associated paraoxonase 1 (PON1) activity. Biochem Biophys Res Commun 2006; 351: 492–498.
   PubMed Web of Science ®Google Scholar
• Gur M, Aslan M, Yildiz A et al. Paraoxonase and arylesterase activities in coronary artery disease. Eur J Clin Invest 2006; 36: 779–787.
   PubMed Web of Science ®Google Scholar